Innova Captab Limited

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

Ask AI

Key metrics

Price as of 2026-07-17

Stock price
₹962.70
Market cap
5,509 Cr
Stock P/E
36.2
P/B
5.05
Dividend yield
0.2%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Sales516 Cr819 Cr1,081 Cr294 Cr612 Cr316 Cr315 Cr352 Cr380 Cr450 Cr448 Cr
Operating expenses (approx.)440 Cr695 Cr914 Cr250 Cr516 Cr266 Cr264 Cr295 Cr324 Cr379 Cr381 Cr
EBITDA76 Cr123 Cr167 Cr44 Cr96 Cr51 Cr51 Cr57 Cr56 Cr71 Cr67 Cr
OPM %14.8%15.0%15.4%15.1%15.7%16.1%16.2%16.1%14.7%15.8%14.9%
Other income4 Cr7 Cr12 Cr2 Cr4 Cr4 Cr3 Cr4 Cr4 Cr2 Cr2 Cr
Interest14 Cr21 Cr21 Cr0.14 Cr0.29 Cr0.17 Cr2 Cr3 Cr5 Cr4 Cr5 Cr
Depreciation8 Cr13 Cr16 Cr5 Cr10 Cr5 Cr10 Cr11 Cr11 Cr11 Cr11 Cr
Profit before tax55 Cr90 Cr130 Cr39 Cr86 Cr46 Cr39 Cr43 Cr39 Cr56 Cr51 Cr
Tax %26.1%27.1%27.2%25.0%25.1%25.0%24.8%27.3%24.4%24.3%24.8%
Net profit40 Cr66 Cr94 Cr29 Cr64 Cr34 Cr30 Cr31 Cr30 Cr42 Cr38 Cr
EPS (₹)₹8.44₹11.47₹18.66₹5.15₹11.27₹5.97₹5.17₹5.42₹5.18₹7.37₹6.65

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2024Mar 2025Mar 2026TTM
Sales1,081 Cr1,244 Cr1,630 CrSign in for TTM
Operating expenses (approx.)927 Cr1,045 Cr1,380 CrSign in for TTM
EBITDA154 Cr198 Cr250 CrSign in for TTM
OPM %14.3%15.9%15.4%Sign in for TTM
Other income12 Cr12 Cr7 CrSign in for TTM
Interest21 Cr2 Cr17 CrSign in for TTM
Depreciation16 Cr25 Cr45 CrSign in for TTM
Profit before tax130 Cr171 Cr188 CrSign in for TTM
Tax %27.2%25.0%25.1%Sign in for TTM
Net profit94 Cr128 Cr141 CrSign in for TTM
EPS (₹)₹18.66₹22.41₹24.63Sign in for TTM
Dividend payout %0.0%0.0%8.1%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2024Mar 2025Mar 2026
Equity capital57 Cr57 Cr57 Cr
Reserves774 Cr902 Cr1,034 Cr
Borrowings245 Cr93 Cr128 Cr
Other liabilities245 Cr528 Cr619 Cr
Total liabilities1,321 Cr1,580 Cr1,837 Cr
Fixed assets (net)340 Cr812 Cr823 Cr
CWIP341 Cr23 Cr16 Cr
Investments0.0000 Cr0.0000 Cr41 Cr
Other assets580 Cr696 Cr923 Cr
Total assets1,321 Cr1,580 Cr1,837 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2024Mar 2025Mar 2026
Cash from operating activity146 Cr64 Cr117 Cr
Cash from investing-499 Cr-152 Cr-107 Cr
Cash from financing361 Cr92 Cr-22 Cr
Net cash flow8 Cr4 Cr-12 Cr
Free cash flow (OCF − Capex)-141 Cr-109 Cr48 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2024Mar 2025Mar 2026
ROCE %12.9%16.5%16.8%
ROE %0.0%0.0%0.0%
Debtor days97——
Inventory days7695103
Days payable94——
Cash conversion cycle7995103
Debt / equity0.290.100.12
Current ratio2.181.971.87
Net debt / EBITDA1.510.390.50

Compare with peers

Loading peers…